Literature DB >> 8119901

Mass spectroscopic analysis of a novel enzymatic reaction. Oxidative decarboxylation of the lantibiotic precursor peptide EpiA catalyzed by the flavoprotein EpiD.

T Kupke1, C Kempter, V Gnau, G Jung, F Götz.   

Abstract

The epidermin biosynthetic reaction between the flavoprotein EpiD and the precursor peptide EpiA was investigated by reversed-phase chromatography and ion spray mass spectrometry. Several products with molecular masses 46 and 104 Da less than that of EpiA were observed; these results were confirmed by using an MBP-EpiD fusion protein as enzyme and the mutant peptides EpiAR-1Q and K-EpiA as substrates. The reaction was inhibited by Zn2+ ions. Modifications were localized in the C-terminal fragment of EpiA as shown by factor Xa cleavage of the products followed by mass spectrometry analysis. In addition, EpiD reacted with the precursor peptides and with proepidermin, indicating that the leader peptide is not necessary for the recognition of EpiA by EpiD. Sequence analysis of modified proepidermin revealed that at least the amino acids Ile(+1)-Tyr+20 are unmodified. The observed decrease in mass of 46 Da and the modification at the C terminus of EpiA is in agreement with the proposed enzymatic function of EpiD, the oxidative decarboxylation of the precursor peptide. In addition, the increased absorbance at 260 nm of the modified peptides indicates the presence of a thioenol group in the C-terminal proepidermin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8119901

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  The flavoprotein MrsD catalyzes the oxidative decarboxylation reaction involved in formation of the peptidoglycan biosynthesis inhibitor mersacidin.

Authors:  Florian Majer; Dietmar G Schmid; Karsten Altena; Gabriele Bierbaum; Thomas Kupke
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

Review 2.  Post-translational modifications of lantibiotics.

Authors:  T Kupke; F Götz
Journal:  Antonie Van Leeuwenhoek       Date:  1996-02       Impact factor: 2.271

Review 3.  Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes.

Authors:  Lindsay M Repka; Jonathan R Chekan; Satish K Nair; Wilfred A van der Donk
Journal:  Chem Rev       Date:  2017-01-30       Impact factor: 60.622

4.  Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms.

Authors:  Jongkon Saising; Linda Dube; Anne-Kathrin Ziebandt; Supayang Piyawan Voravuthikunchai; Mulugeta Nega; Friedrich Götz
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

5.  Crystal structure of the peptidyl-cysteine decarboxylase EpiD complexed with a pentapeptide substrate.

Authors:  M Blaesse; T Kupke; R Huber; S Steinbacher
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

6.  The Radical S-Adenosyl-l-methionine Enzyme MftC Catalyzes an Oxidative Decarboxylation of the C-Terminus of the MftA Peptide.

Authors:  Nathan A Bruender; Vahe Bandarian
Journal:  Biochemistry       Date:  2016-05-13       Impact factor: 3.162

Review 7.  The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.

Authors:  G Bierbaum; F Götz; A Peschel; T Kupke; M van de Kamp; H G Sahl
Journal:  Antonie Van Leeuwenhoek       Date:  1996-02       Impact factor: 2.271

8.  Biosynthesis of the antimicrobial peptide epilancin 15X and its N-terminal lactate.

Authors:  Juan E Velásquez; Xingang Zhang; Wilfred A van der Donk
Journal:  Chem Biol       Date:  2011-07-29

9.  Isolation and characterization of genetically engineered gallidermin and epidermin analogs.

Authors:  B Ottenwälder; T Kupke; S Brecht; V Gnau; J Metzger; G Jung; F Götz
Journal:  Appl Environ Microbiol       Date:  1995-11       Impact factor: 4.792

Review 10.  Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds.

Authors:  John A McIntosh; Mohamed S Donia; Eric W Schmidt
Journal:  Nat Prod Rep       Date:  2009-04       Impact factor: 13.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.